{
  "protocolSection": {
    "identificationModule": {
      "nctId": "NCT02823652",
      "orgStudyIdInfo": {
        "id": "EAQ152",
        "type": null,
        "link": null
      },
      "secondaryIdInfos": [
        {
          "id": "UG1CA189816",
          "type": "NIH",
          "domain": "National Cancer Institute",
          "link": null
        },
        {
          "id": "U10CA180821",
          "type": "NIH",
          "domain": "National Cancer Institute",
          "link": null
        },
        {
          "id": "UG1CA189809",
          "type": "NIH",
          "domain": "National Cancer Institute",
          "link": null
        },
        {
          "id": "UG1CA189819",
          "type": "NIH",
          "domain": "National Cancer Institute",
          "link": null
        },
        {
          "id": "UG1CA189828",
          "type": "NIH",
          "domain": "National Cancer Institute",
          "link": null
        },
        {
          "id": "UG1CA189830",
          "type": "NIH",
          "domain": "National Cancer Institute",
          "link": null
        },
        {
          "id": "UG1CA189863",
          "type": "NIH",
          "domain": "National Cancer Institute",
          "link": null
        },
        {
          "id": "UG1CA189956",
          "type": "NIH",
          "domain": "National Cancer Institute",
          "link": null
        },
        {
          "id": "UG1CA190140",
          "type": "NIH",
          "domain": "National Cancer Institute",
          "link": null
        },
        {
          "id": "UG1CA233160",
          "type": "NIH",
          "domain": "National Cancer Institute",
          "link": null
        },
        {
          "id": "UG1CA233180",
          "type": "NIH",
          "domain": "National Cancer Institute",
          "link": null
        }
      ],
      "organization": {
        "fullName": "ECOG-ACRIN Cancer Research Group",
        "class": "NETWORK"
      },
      "briefTitle": "A randomized study of genetic education versus usual care in tumor profiling for advanced cancer in the ECOG-ACRIN Cancer Research Group (EAQ152)",
      "officialTitle": "A randomized study of genetic education versus usual care in tumor profiling for advanced cancer in the ECOG-ACRIN Cancer Research Group (EAQ152)",
      "acronym": "COMET"
    },
    "descriptionModule": null,
    "conditionsModule": null,
    "designModule": null,
    "armsInterventionsModule": null,
    "outcomesModule": {
      "primaryOutcomes": [
        {
          "measure": "Genetic knowledge",
          "description": "Evaluated with an adapted version of the ClinSeq knowledge scale modified for tumor genetic testing. Assessed at baseline (T0), post-education (T1), and post-disclosure (T2).",
          "timeFrame": "Baseline (T0), post-education (T1, approximately 6-9 days after T0), and post-disclosure (T2, approximately 49 days after T0 or after result disclosure)"
        },
        {
          "measure": "General anxiety",
          "description": "Assessed with 4-item short forms of the Patient-Reported Outcomes Measurement Information System (PROMIS).",
          "timeFrame": "Baseline (T0), post-education (T1, approximately 6-9 days after T0), and post-disclosure (T2, approximately 49 days after T0 or after result disclosure)"
        },
        {
          "measure": "Depression",
          "description": "Assessed with 4-item short forms of the Patient-Reported Outcomes Measurement Information System (PROMIS).",
          "timeFrame": "Baseline (T0), post-education (T1, approximately 6-9 days after T0), and post-disclosure (T2, approximately 49 days after T0 or after result disclosure)"
        },
        {
          "measure": "State anxiety",
          "description": "Assessed with 20 items from the State-Trait Anxiety Inventory.",
          "timeFrame": "Baseline (T0), post-education (T1, approximately 6-9 days after T0), and post-disclosure (T2, approximately 49 days after T0 or after result disclosure)"
        },
        {
          "measure": "Cancer-specific distress",
          "description": "Measured with an adapted 14-item version of the Impact of Events Scale.",
          "timeFrame": "Baseline (T0), post-education (T1, approximately 6-9 days after T0), and post-disclosure (T2, approximately 49 days after T0 or after result disclosure)"
        }
      ],
      "secondaryOutcomes": [
        {
          "measure": "Health literacy",
          "description": "Assessed with a 3-item scale. Higher scores indicated lower health literacy. Evaluated as a moderator of changes in knowledge and distress.",
          "timeFrame": "Baseline (T0)"
        },
        {
          "measure": "Uncertainty about tumor genetic testing",
          "description": "Assessed with a 3-item scale adapted for tumor genetic testing from the uncertainty subscale of the Multi-Dimensional Impact of Cancer Risk Assessment questionnaire.",
          "timeFrame": "Baseline (T0), post-education (T1, approximately 6-9 days after T0), and post-disclosure (T2, approximately 49 days after T0 or after result disclosure)"
        },
        {
          "measure": "Perceived utility of tumor genetic testing",
          "description": "Assessed with 10 items assessing patient perceptions of the utility of genetic information.",
          "timeFrame": "Baseline (T0), post-education (T1, approximately 6-9 days after T0), and post-disclosure (T2, approximately 49 days after T0 or after result disclosure)"
        },
        {
          "measure": "Satisfaction with the disclosure of genetic results",
          "description": "Assessed with an adapted 9-item scale used in related research.",
          "timeFrame": "Post-disclosure (T2, approximately 49 days after T0 or after result disclosure)"
        }
      ]
    },
    "eligibilityModule": null
  }
}